DD96144A5 - - Google Patents

Info

Publication number
DD96144A5
DD96144A5 DD159910A DD15991071A DD96144A5 DD 96144 A5 DD96144 A5 DD 96144A5 DD 159910 A DD159910 A DD 159910A DD 15991071 A DD15991071 A DD 15991071A DD 96144 A5 DD96144 A5 DD 96144A5
Authority
DD
German Democratic Republic
Application number
DD159910A
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Publication of DD96144A5 publication Critical patent/DD96144A5/xx

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • A61K31/52Purines, e.g. adenine

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
DD159910A 1971-01-26 1971-12-17 DD96144A5 (en:Method)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US10994271A 1971-01-26 1971-01-26

Publications (1)

Publication Number Publication Date
DD96144A5 true DD96144A5 (en:Method) 1973-03-12

Family

ID=22330411

Family Applications (2)

Application Number Title Priority Date Filing Date
DD159910A DD96144A5 (en:Method) 1971-01-26 1971-12-17
DD159688A DD96400A5 (en:Method) 1971-01-26 1971-12-17

Family Applications After (1)

Application Number Title Priority Date Filing Date
DD159688A DD96400A5 (en:Method) 1971-01-26 1971-12-17

Country Status (18)

Country Link
AT (2) AT310939B (en:Method)
AU (1) AU465875B2 (en:Method)
BE (2) BE776769A (en:Method)
BR (2) BR7108429D0 (en:Method)
CA (2) CA983850A (en:Method)
DD (2) DD96144A5 (en:Method)
DE (2) DE2163055A1 (en:Method)
DK (2) DK130389B (en:Method)
ES (2) ES398108A1 (en:Method)
FR (2) FR2123277B1 (en:Method)
GB (1) GB1370904A (en:Method)
HU (2) HU162347B (en:Method)
IE (2) IE35937B1 (en:Method)
LU (1) LU64664A1 (en:Method)
NL (2) NL7117404A (en:Method)
NO (2) NO135891C (en:Method)
SE (2) SE391127B (en:Method)
ZA (2) ZA718326B (en:Method)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4917894A (en) * 1988-06-29 1990-04-17 Beecham Inc. Rapid-onset long-duration oral anesthetic composition
US6030974A (en) * 1997-04-02 2000-02-29 The Regents Of The University Of California Method of anesthesia
US6326020B1 (en) 1997-05-16 2001-12-04 Children's Medical Center Corporation Local anesthetic formulations
RU2277097C1 (ru) * 2004-12-27 2006-05-27 Институт Молекулярной Генетики Российской Академии Наук (Имг Ран) Высокомеченный тритием дигидрохлорид [3h]сакситоксина
ES2691411T3 (es) 2006-03-27 2018-11-27 Wex Medical Limited Uso de bloqueadores de los canales de sodio para el tratamiento del dolor neuropático que se desarrolla como consecuencia de la quimioterapia
US8952152B2 (en) 2009-03-24 2015-02-10 Proteus S.A. Methods for purifying phycotoxins, pharmaceutical compositions containing purified phycotoxins, and methods of use thereof
PL2968225T3 (pl) 2013-03-15 2019-08-30 The Children's Medical Center Corporation Preparaty skojarzone neosaksytoksyny do przedłużonego znieczulenia miejscowego

Also Published As

Publication number Publication date
ZA718327B (en) 1972-09-27
FR2123278B1 (en:Method) 1975-08-01
BR7108429D0 (pt) 1973-06-14
NO135892B (en:Method) 1977-03-14
DK131606B (da) 1975-08-11
CA983850A (en) 1976-02-17
BE776768A (fr) 1972-06-16
IE35937B1 (en) 1976-07-07
DE2163054A1 (de) 1974-05-02
FR2123277B1 (en:Method) 1975-06-13
DK130389C (en:Method) 1975-07-14
DE2163055A1 (de) 1972-10-12
AT310938B (de) 1973-10-25
HU162347B (en:Method) 1973-02-28
SE391127B (sv) 1977-02-07
ES398108A1 (es) 1975-03-01
IE35937L (en) 1972-07-26
DK130389B (da) 1975-02-17
SE391286B (sv) 1977-02-14
CA986012A (en) 1976-03-23
AU3710071A (en) 1973-06-28
FR2123277A1 (en:Method) 1972-09-08
IE35910L (en) 1972-07-26
ES398109A1 (es) 1975-03-16
FR2123278A1 (en:Method) 1972-09-08
BE776769A (fr) 1972-06-16
NO135892C (no) 1978-05-16
NO135891B (en:Method) 1977-03-14
HU162185B (en:Method) 1973-01-29
NL7117401A (en:Method) 1972-07-28
LU64664A1 (en:Method) 1972-08-23
DE2163054B2 (de) 1978-06-01
DK131606C (da) 1976-01-12
AT310939B (de) 1973-10-25
ZA718326B (en) 1972-09-27
IE35910B1 (en) 1976-06-23
AU465875B2 (en) 1975-10-09
DE2163054C3 (de) 1979-02-01
NL7117404A (en:Method) 1972-07-28
NO135891C (no) 1978-05-16
GB1370904A (en) 1974-10-16
BR7108428D0 (pt) 1973-06-14
AU3710171A (en) 1973-06-28
DD96400A5 (en:Method) 1973-03-20

Similar Documents

Publication Publication Date Title
FR2123278B1 (en:Method)
AU2691671A (en:Method)
AU2742671A (en:Method)
AU2894671A (en:Method)
AU3005371A (en:Method)
AU2684071A (en:Method)
AU2941471A (en:Method)
AU2952271A (en:Method)
AU2726271A (en:Method)
AU2880771A (en:Method)
AU3025871A (en:Method)
AU3038671A (en:Method)
AU2963771A (en:Method)
AU2669471A (en:Method)
AU2684171A (en:Method)
AU2940971A (en:Method)
AU2724971A (en:Method)
AU2740271A (en:Method)
AU2885171A (en:Method)
AU2755871A (en:Method)
AU2938071A (en:Method)
AU2836771A (en:Method)
AU2837671A (en:Method)
AU2930871A (en:Method)
AU2927871A (en:Method)